Mersana Therapeutics, Inc.
MRSN
$7.68
$0.0250.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.12% | -24.95% | 27.77% | 72.39% | 55.31% |
| Total Depreciation and Amortization | -28.78% | -25.30% | -10.51% | -5.85% | 24.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.93% | -18.54% | -21.19% | 2.17% | -30.06% |
| Change in Net Operating Assets | -4.39% | 49.98% | 47.50% | 83.51% | 85.39% |
| Cash from Operations | -3.42% | 10.20% | 39.77% | 81.39% | 64.66% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 137.29% | 143.50% | -72.69% | 209.40% |
| Cash from Investing | -92.84% | 137.22% | 148.16% | -72.57% | 201.38% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6,574.47% | -4,726.15% | -3,074.24% | 64.62% | 28.79% |
| Issuance of Common Stock | -85.50% | -- | 44.30% | -- | -99.73% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2,131.37% | -153.82% | -2,129.35% | 84.25% | -99.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -56.38% | 94.50% | 346.39% | -65.47% | -374.05% |